U.S. Defense Secretary Pete Hegseth announced a new screening programme on Wednesday to test military service members for testosterone deficiency [1].
The policy represents a shift in military medical priorities, linking hormone levels to the operational effectiveness and cultural identity of the U.S. armed forces.
Under the new guidelines, service members aged 30 and older must undergo mandatory annual testosterone testing [1]. Personnel under the age of 30 may opt in for the screening on a voluntary basis [2]. If a deficiency is identified, the Department of Defense will offer testosterone-replacement therapy, though the treatment remains entirely voluntary [3].
Hegseth said the initiative is intended to restore and optimize the natural capabilities of warfighters. He said the goal is to reinforce a "warrior culture" within the military ranks [4].
"This initiative is not about artificial enhancement, it’s about restoring and optimizing your natural capabilities," Hegseth said [5].
The Secretary framed the medical screenings as a necessity for maintaining peak performance in the field. "Testing for testosterone deficiency is necessary to allow our troops to operate at their highest level," Hegseth said [6].
The programme focuses on the physiological readiness of personnel, an approach that prioritizes hormonal health as a component of combat readiness. The Department of Defense has not yet released specific clinical benchmarks that will define a "deficiency" for the purposes of the mandatory annual tests [1].
“"This initiative is not about artificial enhancement, it’s about restoring and optimizing your natural capabilities."”
This policy signals a move toward integrating endocrine health into the standard readiness metrics of the U.S. military. By mandating screenings for older personnel and linking hormone levels to 'warrior culture,' the Department of Defense is treating testosterone levels as a strategic asset for operational performance rather than solely a matter of individual medical care.
